In general, the GRHL2/ZEB1 feedback loop was identified as a key regulator of EMP and associated traits in breast cancer, lung cancer [36], colorectal cancer [37] and ovarian cancer [38, 39]. Here, GRHL2 is linked to breast carcinoma.